UM cuts the ribbon on new biomed research site

Florida officials took another step in their long quest to build a major biotech hub with the news that the first building in the University of Miami's research complex will officially open its doors today. The 252,000-square-foot building offers wet and dry labs for researchers and already has a few tenants signed up. "The University of Miami Life Science & Technology Park is going to lead the way in biomedical research for South Florida, Latin America and the Caribbean Basin," said Dean Goldschmidt. "This state-of-the-art complex will push research to new heights and help us advance new therapies and preventive strategies for patients around the world, while transforming Miami into a world-class destination for research, technology and the absolute best, most compassionate medical care." Release

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.